RSL Investments

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2018	Quince Therapeutics	$76.0M Series B	—	Stuart Peterson, Cowles Ventures, Founders Fund, Transformation Capital, James Hong, Breakout Ventures, Dolby Family Ventures, EPIQ Capital Group, Huizenga Capital Management, Lamond Family, Pfizer, Michael Dixon, Takeda Ventures, Verily, Vulcan Capital

Total Raised

N/A

Valuation

N/A